Neuromyelitis optica spectrum disorder
NMOSD · Rare Disease · 3 drugs · 1 indications
Autoimmune CNS disorder affecting optic nerves and spinal cord.
Competitive Landscape (3 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Enspryng | ROG.SW | Anti-IL-6R (Recycling) | Antibody | SC | APPROVED |
| Ultomiris | AZN | C5 inhibitor | Antibody | IV | APPROVED |
| UPLIZNA | AMGN | Anti-CD19 monoclonal antibody | Monoclonal antibody | IV | APPROVED |
Indications (1)
Neuromyelitis Optica Spectrum Disorder
Upcoming Catalysts
Ultomiris - IgAN - Ph3 - Topline (ICAN)CLINICAL
AZNH1 2026
Ultomiris - HSCT-TMA - Ph3 - ToplineCLINICAL
AZNH1 2026
Data from Supabase · Updated 2026-03-24